Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB14 in Adult Patients With Advanced Malignant Solid Tumours.

NCT06304818 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

515

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Solid Tumours

Interventions

DRUG: SCTB14

Sponsor

Sinocelltech Ltd.